InsiderTrades

Form 4 for BVS Bioventus Inc.

Accepted 2023-03-16 00:00:00 ET · period of report 2022-03-14 · accession 0000899243-23-008793 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-03-16 2023-03-14 BVS HAWKINS WILLIAM A Dir M - OptEx — +3,949 96.3K +4% —
D 2023-03-16 2022-03-14 BVS HAWKINS WILLIAM A Dir A - Grant $0.00 +3,949 3,949 New $0
D 2023-03-16 2023-03-14 BVS HAWKINS WILLIAM A Dir M - OptEx $0.00 -3,949 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2023-03-14 M A 3,949 — 96,310 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
2 Derivative Restricted Stock Units 2022-03-14 A A 3,949 $0.00 3,949 D — · — to — 3,949 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. (F2) The RSUs vest in full on March 14, 2023.
3 Derivative Restricted Stock Units 2023-03-14 M D 3,949 $0.00 0 D — · — to — 3,949 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. (F2) The RSUs vest in full on March 14, 2023.